155 related articles for article (PubMed ID: 38127827)
21. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant.
Gupta S; Weiss A; Kumar G; Wang S; Nel A
J Biol Chem; 1994 Jun; 269(25):17349-57. PubMed ID: 7516337
[TBL] [Abstract][Full Text] [Related]
22. B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.
Papin C; Eychène A; Brunet A; Pagès G; Pouysségur J; Calothy G; Barnier JV
Oncogene; 1995 Apr; 10(8):1647-51. PubMed ID: 7731720
[TBL] [Abstract][Full Text] [Related]
23. Growth factor induced MEK activation is primarily mediated by an activator different from c-raf.
Zheng CF; Ohmichi M; Saltiel AR; Guan KL
Biochemistry; 1994 May; 33(18):5595-9. PubMed ID: 8180183
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel inhibitor of mitogen-activated protein kinase kinase.
Favata MF; Horiuchi KY; Manos EJ; Daulerio AJ; Stradley DA; Feeser WS; Van Dyk DE; Pitts WJ; Earl RA; Hobbs F; Copeland RA; Magolda RL; Scherle PA; Trzaskos JM
J Biol Chem; 1998 Jul; 273(29):18623-32. PubMed ID: 9660836
[TBL] [Abstract][Full Text] [Related]
25. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
27. Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.
Wu X; Noh SJ; Zhou G; Dixon JE; Guan KL
J Biol Chem; 1996 Feb; 271(6):3265-71. PubMed ID: 8621729
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of agonist-stimulated MEK activation determines the susceptibility of mitogen-activated protein (MAP) kinase to inhibition in rat aortic smooth muscle cells.
Plevin R; Scott PH; Robinson CJ; Gould GW
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):657-63. PubMed ID: 8809060
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf.
Ueda Y; Hirai Si; Osada Si; Suzuki A; Mizuno K; Ohno S
J Biol Chem; 1996 Sep; 271(38):23512-9. PubMed ID: 8798560
[TBL] [Abstract][Full Text] [Related]
30. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes.
Tordai A; Franklin RA; Patel H; Gardner AM; Johnson GL; Gelfand EW
J Biol Chem; 1994 Mar; 269(10):7538-43. PubMed ID: 8125975
[TBL] [Abstract][Full Text] [Related]
31. MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells.
Weiss RH; Maga EA; Ramirez A
Am J Physiol; 1998 Jun; 274(6):C1521-9. PubMed ID: 9696694
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals.
von Gise A; Lorenz P; Wellbrock C; Hemmings B; Berberich-Siebelt F; Rapp UR; Troppmair J
Mol Cell Biol; 2001 Apr; 21(7):2324-36. PubMed ID: 11259582
[TBL] [Abstract][Full Text] [Related]
33. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580.
Kalmes A; Deou J; Clowes AW; Daum G
FEBS Lett; 1999 Feb; 444(1):71-4. PubMed ID: 10037150
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
[TBL] [Abstract][Full Text] [Related]
35. Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway.
Kawaguchi M; Kokubu F; Odaka M; Watanabe S; Suzuki S; Ieki K; Matsukura S; Kurokawa M; Adachi M; Huang SK
J Allergy Clin Immunol; 2004 Aug; 114(2):444-50. PubMed ID: 15316530
[TBL] [Abstract][Full Text] [Related]
36. Regulation of lymphotoxin production by the p21ras-raf-MEK-ERK cascade in PHA/PMA-stimulated Jurkat cells.
Li YQ; Hii CS; Costabile M; Goh D; Der CJ; Ferrante A
J Immunol; 1999 Mar; 162(6):3316-20. PubMed ID: 10092784
[TBL] [Abstract][Full Text] [Related]
37. Identification of 2 serine residues of MEK-1 that are differentially phosphorylated during activation by raf and MEK kinase.
Yan M; Templeton DJ
J Biol Chem; 1994 Jul; 269(29):19067-73. PubMed ID: 8034665
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
[TBL] [Abstract][Full Text] [Related]
40. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
